Table 1 Characteristics of the cohort of patients
Characteristics | Items | N (%) |
|---|---|---|
Sex | Female | 8/20 (40%) |
Male | 12/20 (60%) | |
Age | Mean | 64.5 |
Median (range) | 68.55 (47–81) | |
St.dev | 11.2 | |
Portal vein thrombosis | No | 14/20 (65%) |
Yes | 6/20 (35%) | |
Tumor location | Right lobe | 7/22 (32%) |
Left lobe | 4/22 (18%) | |
Bilateral lobe | 11/22 (50%) | |
Stage T | T1 | 3/20 (15%) |
T2 | 4/20 (20%) | |
T3 | 12/20 (60%) | |
T4 | 1/20 (5%) | |
Stage N | N0 | 17/20 (85%) |
N1 | 3/20 (15%) | |
Stage M | M0 | 17/20 (85%) |
M1 | 3/20 (15%) | |
AJCC stage | I | 3/20 (15%) |
II | 4/20 (20%) | |
III | 8/20 (40%) | |
IV | 5/20 (25%) | |
Okuda stage | I | 16/20 (80%) |
II | 4/20 (20%) | |
BCLC stage | 0 | 1 (5%) |
A | 3 (15%) | |
B | 8 (40%) | |
C | 8 (40%) | |
Child-pugh stage | A | 18 (90%) |
B | 2 (10%) | |
Hepatitis | No | 5 (25%) |
B | 10 (50%) | |
C | 5 (25%) | |
B and C | 0 (0%) | |
Initial Alpha-fetoprotein (ng/mL) | Median (range) | 301.4 (2.8 – >52131) |
Initial white blood count (kU/dL) | Median (range) | 5.2 (3.3 – 10.7) |
Initial haemoglobin level (g/dL) | Median (range) | 12.0 (6.7 – 15.5) |
Initial GPT level (U/L) | Median (range) | 41.5 (18.0 – 244.0) |
Initial total bilirubin level (mg/dL) | Median (range) | 0.8 (0.3 – 1.9) |
Initial tumor volume (cm 3 ) | Median (range) | 124 (6 – 848) |
Total liver volume (cm 3 ) | Median (range) | 1343 (928 – 2198) |